Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors’ reply
Goncalves, J.; Magro, F.; Danese, S.; Lakatos, P. L.; Ben-Horin, S.
- 期刊名称Alimentary Pharmacology & Therapeutics
- 作者Goncalves, J.; Magro, F.; Danese, S.; Lakatos, P. L.; Ben-Horin, S.
- 卷第48卷
- 期第5期
- 印刷ISSN0269-2813
- 文件大小371.40KB
- 发表时间2018-09
- DOI10.1111/apt.14860
- 页码575-576